← Evidence map

ArticleOncology letters2024

[Retracted] Serum miR‑338‑5p has potential for use as a tumor marker for retinoblastoma.

Peng Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 38572062